309 related articles for article (PubMed ID: 162517)
1. Adrenal suppression with aminoglutethimide. III. Comparison of plasma delta 4- and delta 5-steroids in postmenopausal women treated for breast carcinoma.
Samojlik E; Santen RJ
J Clin Endocrinol Metab; 1978 Oct; 47(4):717-24. PubMed ID: 162517
[TBL] [Abstract][Full Text] [Related]
2. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
[TBL] [Abstract][Full Text] [Related]
3. Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma.
Samojlik E; Veldhuis JD; Wells SA; Santen RJ
J Clin Invest; 1980 Mar; 65(3):602-12. PubMed ID: 6986409
[TBL] [Abstract][Full Text] [Related]
4. Steroid hormone profiles in women treated with aminoglutethimide for metastatic carcinoma of the breast.
Samojlik E; Santen RJ; Kirschner MA; Ertel NH
Cancer Res; 1982 Aug; 42(8 Suppl):3349s-3352s. PubMed ID: 7083199
[TBL] [Abstract][Full Text] [Related]
5. ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism.
Siegel SF; Finegold DN; Lanes R; Lee PA
N Engl J Med; 1990 Sep; 323(13):849-54. PubMed ID: 2168515
[TBL] [Abstract][Full Text] [Related]
6. The effects of spironolactone on adrenal steroidogenesis in hirsute women.
Serafini P; Lobo RA
Fertil Steril; 1985 Nov; 44(5):595-9. PubMed ID: 2996951
[TBL] [Abstract][Full Text] [Related]
7. Endocrine effects of aminoglutethimide plus hydrocortisone versus effects of high dose of hydrocortisone alone in postmenopausal metastatic breast cancer.
Alexieva-Figusch J; de Jong FH; Lamberts WJ; van Gilse HA; Klign JG
Eur J Cancer Clin Oncol; 1987 Sep; 23(9):1349-56. PubMed ID: 2960533
[TBL] [Abstract][Full Text] [Related]
8. How effective is surgical adrenalectomy in lowering steroid hormone concentrations?
Worgul TJ; Santen RJ; Samojlik E; Wells SA
J Clin Endocrinol Metab; 1982 Jan; 54(1):22-6. PubMed ID: 6459336
[TBL] [Abstract][Full Text] [Related]
9. Testicular steroidogenesis in adult men with human chorionic gonadotropin-producing tumors.
Rieu M; Reznik Y; Vannetzel JM; Mahoudeau J; Berrod JL; Kuhn JM
J Clin Endocrinol Metab; 1995 Aug; 80(8):2404-9. PubMed ID: 7629236
[TBL] [Abstract][Full Text] [Related]
10. Effect of exogenous estrogen on serum pregnenolone, cortisol, and androgens in postmenopausal women.
Abraham GE; Maroulis GB
Obstet Gynecol; 1975 Mar; 45(3):271-4. PubMed ID: 163457
[TBL] [Abstract][Full Text] [Related]
11. Effect of androgen on adrenal steroidogenesis in normal women.
Vermesh M; Silva PD; Rosen GF; Vijod AG; Lobo RA
J Clin Endocrinol Metab; 1988 Jan; 66(1):128-30. PubMed ID: 2826523
[TBL] [Abstract][Full Text] [Related]
12. The effect of serum prolactin on plasma adrenal androgens and the production and metabolic clearance rate of dehydroepiandrosterone sulfate in normal and hyperprolactinemic subjects.
Schiebinger RJ; Chrousos GP; Cutler GB; Loriaux DL
J Clin Endocrinol Metab; 1986 Jan; 62(1):202-9. PubMed ID: 2999177
[TBL] [Abstract][Full Text] [Related]
13. Endocrine and therapeutic effects of aminoglutethimide in premenopausal patients with breast cancer.
Harris AL; Dowsett M; Jeffcoate SL; McKinna JA; Morgan M; Smith IE
J Clin Endocrinol Metab; 1982 Oct; 55(4):718-22. PubMed ID: 6213633
[TBL] [Abstract][Full Text] [Related]
14. Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer.
Harris AL; Dowsett M; Smith IE; Jeffcoate SL
Br J Cancer; 1983 May; 47(5):621-7. PubMed ID: 6221746
[TBL] [Abstract][Full Text] [Related]
15. Hydrocortisone alone vs hydrocortisone plus aminoglutethimide: a comparison of the endocrine effects in postmenopausal breast cancer.
Harris AL; Dowsett M; Smith IE; Jeffcoate S
Eur J Cancer Clin Oncol; 1984 Apr; 20(4):463-9. PubMed ID: 6233150
[TBL] [Abstract][Full Text] [Related]
16. Normative data for adrenal steroidogenesis in a healthy pediatric population: age- and sex-related changes after adrenocorticotropin stimulation.
Lashansky G; Saenger P; Fishman K; Gautier T; Mayes D; Berg G; Di Martino-Nardi J; Reiter E
J Clin Endocrinol Metab; 1991 Sep; 73(3):674-86. PubMed ID: 1651957
[TBL] [Abstract][Full Text] [Related]
17. Ovarian and adrenal contributions to peripheral steroid levels in postmenopausal women.
Maroulis GB; Abraham GE
Obstet Gynecol; 1976 Aug; 48(2):150-4. PubMed ID: 133306
[TBL] [Abstract][Full Text] [Related]
18. Marked attenuation of ultradian and circadian rhythms of dehydroepiandrosterone in postmenopausal women: evidence for a reduced 17,20-desmolase enzymatic activity.
Liu CH; Laughlin GA; Fischer UG; Yen SS
J Clin Endocrinol Metab; 1990 Oct; 71(4):900-6. PubMed ID: 2169480
[TBL] [Abstract][Full Text] [Related]
19. Endocrine effects of low dose aminoglutethimide with hydrocortisone--an optimal hormone suppressive regimen.
Harris AL; Dowsett M; Cantwell BM; Sainsbury JR; Needham G; Farndon J; Wilson R
Breast Cancer Res Treat; 1986; 7 Suppl():S69-72. PubMed ID: 2943338
[TBL] [Abstract][Full Text] [Related]
20. Influence of ACTH on aminoglutethimide induced reduction of plasma steroids in postmenopausal breast cancer.
Bruning PF; Bonfrer JM; De Jong-Bakker M; Nooyen W
J Steroid Biochem; 1984 Sep; 21(3):293-8. PubMed ID: 6092781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
